ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $912,188 | -59.6% | 45,473 | -43.2% | 0.00% | -71.4% |
| Q2 2023 | $2,259,960 | +677.7% | 80,112 | +374.2% | 0.01% | +600.0% |
| Q1 2023 | $290,577 | -54.2% | 16,894 | -42.3% | 0.00% | -66.7% |
| Q3 2022 | $634,000 | -33.5% | 29,269 | +41.5% | 0.00% | -25.0% |
| Q1 2022 | $954,000 | +147.2% | 20,679 | +350.7% | 0.00% | +300.0% |
| Q4 2021 | $386,000 | -62.9% | 4,588 | -76.6% | 0.00% | -75.0% |
| Q2 2021 | $1,041,000 | +85.2% | 19,577 | +80.8% | 0.00% | 0.0% |
| Q4 2020 | $562,000 | – | 10,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |